Related references
Note: Only part of the references are listed.Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
Ehsan Rahimy et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
Joao Pinheiro-Costa et al.
OPHTHALMOLOGICA (2015)
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Heidi Fassnacht-Riederle et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
Yoshihiro Yonekawa et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
Vincent Y. Ho et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
Benjamin Bakall et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
Hyung Cho et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Diana V. Do et al.
OPHTHALMOLOGY (2012)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment Three-Year Randomized Trial Results
Michael J. Elman et al.
OPHTHALMOLOGY (2012)
The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
Diana V. Do et al.
OPHTHALMOLOGY (2011)
The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Paul Mitchell et al.
OPHTHALMOLOGY (2011)
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2010)
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study) 12-Month Data: Report 2
Michel Michaelides et al.
OPHTHALMOLOGY (2010)
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema
D. V. Do et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
J. Fernando Arevalo et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema
Ingrid U. Scott et al.
OPHTHALMOLOGY (2007)
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema
Quan Dong Nguyen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment
Robert L. Avery
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Share Paper
